Amino Acid Substitutions At Position 38 of the Drβ Polypeptide Confer Susceptibility to and Protection From Primary Sclerosing Cholangitis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Previous studies based on serological HLA phenotyping have implicated genes in the HLA class II region in susceptibility to and protection from primary sclerosing cholangitis. In a recent report, the HLA DRw52a antigen was present in all 29 patients who had been referred for liver transplantation. In this study, HLA DRB, DQA and DQB genotypes were studied using gene amplification and sequence–specific oligonucleotide probing in 71 patients with primary sclerosing cholangitis and 68 healthy controls to determine the frequency among the patients of the DRB3★0101 allele that encodes DRw52a and whether other class II alleles are involved in susceptibility or protection. DRB3★0101 was the most strongly associated allele, being present in 55% of the patients and 22% of the controls. Survival among the DRB3★0101–positive patients was reduced compared with the DRB3★0101–negative patients. Both DRB3★0101 and DRB5★0101, a possible second DRB susceptibility allele, encode a leucine residue at position 38 of the DRβ molecule. The DRB4★0101 allele, which encodes DRw53 and may be protective, encodes an alanine residue at this position. Susceptibility to and protection from primary sclerosing cholangitis may result from amino acid substitutions at position 38 of the DRβ molecule because maximum relative risk was conferred by two leucine–38-containing DRβ molecules, whereas minimum relative risk was conferred by two alanine–38-containing molecules. (Hepatology 1992;16:390-395.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Natural history and prognostic variables in primary sclerosing cholangitis
Farrant, J. M., Hayllar, K. M., Wilkinson, M. L., Karani, J., Portmann, B. C., Westaby, D., & Williams, R. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90673-9 · Cited by 468
Self-citationDoherty, D. G., Vaughan, R. W., Donaldson, P. T., & Mowat, A. P. (1992) · Human Immunology · doi:10.1016/0198-8859(92)90085-2 · Cited by 100
Self-citation
Cited by
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Primary sclerosing cholangitis
Hirschfield, G. M., Karlsen, T. H., Lindor, K. D., & Adams, D. H. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60096-3 · Cited by 592
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.052 · Cited by 436
Satsangl, J., Farrant, J. M., Jewell, D. P., Bell, J. I., Welsh, K. I., Bunce, M., & Julier, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90734-5 · Cited by 368
Self-citation
Metadata
- Authors
- Farrant, M. J., Doherty, D. G., Donaldson, P. T., Vaughan, R. W., Hayllar, K. M., Welsh, K. I., Eddleston, A. L. W. F., & Williams, R.
- Venue
- Hepatology
- Published
- 1992-08
- Volume
- 16
- Issue
- 2
- Pages
- 390-395
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2006750223
- Cited by
- 137
- References
- 3
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amino Acid Substitutions At Position 38 of the Drβ Polypeptide Confer Susceptibility to and Protection From Primary Sclerosing Cholangitis. https://app.cochat.ai/papers/10.1002/hep.1840160217
- The paper
- Farrant, M. J., Doherty, D. G., Donaldson, P. T., Vaughan, R. W., Hayllar, K. M., Welsh, K. I., Eddleston, A. L. W. F., & Williams, R. (1992). Amino Acid Substitutions At Position 38 of the Drβ Polypeptide Confer Susceptibility to and Protection From Primary Sclerosing Cholangitis. Hepatology. https://doi.org/10.1002/hep.1840160217
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.